一项全国性流行病调查研究：1990～2013年中国慢性阻塞性肺疾病死亡率与流行病调查
2017/10/23
背景：中国所有省份过去二十年的COPD死亡率和流行趋势尚无数据尚属未知。我们使用2013年“全球疾病负担报告”（GBD 2013）的数据来估算1990年至2013年中国在省级别的COPD死亡率和患病率。
方法:根据GBD 2013中使用的一般分析策略，我们分析了中国年龄、性别、省份死亡率和COPD患病率。在1990年至2013年期间，对33个省级行政单位评估了COPD死亡率和患病率的水平和趋势。
结果:2013年中国COPD死亡人数为910,809人，占世界COPD死亡人数的31.1％。从1990年到2013年，各省年龄标准化COPD死亡率下降，其中黑龙江（70.2％）和吉林（70.0％）降幅最大，贵州降幅最小（26.8％）。 2013年每100,000人死亡人数，男性数据最高的是贵州（196.0），最低的是天津（34.0），女性数据最高的是甘肃省（141.1），最低的是北京（23.7）。 COPD病例从1990年的3240万急剧增加到2013年的5480万。COPD年龄标准化患病率保持稳定，各省几乎没有差异。
结论:COPD在中国西部许多省份仍然是一个巨大的健康负担。由于中国人口迅速老龄化，COPD患病人数的大幅增加是一个巨大的挑战。应在省级制定有针对性的控制和预防策略，减轻COPD造成的负担。
(A Subnational Analysis of Mortality and Prevalence of COPD in China From 1990 to 2013: Findings From the Global Burden of Disease Study 2013[J]. CHEST Journal, 2016, 150(6): 1269-1280.)
A Subnational Analysis of Mortality and Prevalence of COPD in China From 1990 to 2013
Yin P, Wang H, Vos T, et al.
Abstract
Background:The trends of COPD mortality and prevalence over the past 2 decades across all provinces remain unknown in China. We used data from the Global Burden of Disease Study 2013 (GBD 2013) to estimate the mortality and prevalence of COPD during 1990 to 2013 at a provincial level.Methods:Following the general analytic strategy used in GBD 2013, we analyzed the age- sex- and province-specific mortality and prevalence of COPD in China. Levels of and trends in COPD mortality and prevalence were assessed for 33 province-level administrative units during 1990 to 2013.
Results:In 2013, there were 910,809 deaths from COPD in China, accounting for 31.1% of the total deaths from COPD in the world. From 1990 to 2013, the age-standardized COPD mortality rate decreased in all provinces, with the highest reduction in Heilongjiang (70.2%) and Jilin (70.0%) and the lowest reduction in Guizhou (26.8%). In 2013, the death rate per 100,000 was highest in Guizhou (196.0) and lowest in Tianjin (34.0) among men and highest in Gansu (141.1) and lowest in Beijing (23.7) among women. The number of COPD cases increased dramatically from 32.4 million in 1990 to 54.8 million in 2013. The age-standardized prevalence rate of COPD remained stable overall and varied little for all provinces.
Conclusions:COPD remains a huge health burden in many western provinces in China. The substantial increase in COPD cases represents an ongoing challenge given the rapidly aging Chinese population. A targeted control and prevention strategy should be developed at a provincial level to reduce the burden caused by COPD.
